HansaBiomed at ISEV 2025

From April 24-27 at the International Society for Extracellular Vesicles Annual Meeting 2025 (ISEV2025) in Vienna, Austria, NAP4DIVE‘s industrial partner, HansaBioMed Life Sciences Ltd, presented their ultrafiltration devices, that will be used for upscaling the production of nanoparticles within NAP4DIVE.

HansaBiomed is responsible for the upscaling and manufacturing of nanoparticles within the project.

The ost promising nanoparticles at crossing the blood-brain barrier (BBB) will be tested on a BBB-on-Chip. With this NAP4DIVE address a significant clinical challenge: drug delivery to the brain, which is hindered by the blood-brain barrier using non-animal tools.

The event welcomed over 1800 participants, including leading scientists from around the world. The event showcased cutting-edge research and technology in the field of extracellular vesicles. The Society is renowned for its work in #standardization through the MISEV guidelines.